During the past decade, KLV Arstikabinet conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "KLV Arstikabinet" are "Postmenopausal Osteoporosis" (1 trials) and "Postmenopausal Women With Osteoporosis" (1 trials). Many other conditions were trialed in "KLV Arstikabinet" in a lesser frequency.

Most popular intervention types in "KLV Arstikabinet" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "US-licensed Prolia" (2 trials), "CT-P41" (1 trials) and "FKS518" (1 trials). Other intervention names were less common.

The vast majority of trials in "KLV Arstikabinet" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "KLV Arstikabinet". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in KLV Arstikabinet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in KLV Arstikabinet, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".